SARS‐CoV‐2 variants and vulnerability at the global level
Numerous variants of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
pandemic have evolved. Viral variants may evolve with harmful susceptibility to the immunity …
pandemic have evolved. Viral variants may evolve with harmful susceptibility to the immunity …
Association of neutralizing breadth against SARS-CoV-2 with inoculation orders of heterologous prime-boost vaccines
Y Zhu, Y Lu, C Zhou, G Tong, M Gao, Y Zhan, Y Wang… - Med, 2022 - cell.com
Background Emerging evidence suggests heterologous prime-boost COVID-19 vaccination
as a superior strategy than homologous schedules. Animal experiments and clinical …
as a superior strategy than homologous schedules. Animal experiments and clinical …
Finite neutralisation breadth of omicron after repeated vaccination
Y Zhu, Y Lu, L Tang, C Zhou, R Liang, M Cui… - The Lancet …, 2022 - thelancet.com
Exposure to SARS-CoV-2 antigens by vaccination or infection expands the breadth of
neutralising antibodies to better recognise mutated variants, 1 which is part of the reason …
neutralising antibodies to better recognise mutated variants, 1 which is part of the reason …
Humoral immune response to omicron infection in long-term Wuhan-Hu-1-imprinted population
Y Lu, Y Zhu, Y Zheng, L Tang, H Chen, C Zhou, J Luo… - 2023 - researchsquare.com
Recent WHO vaccination guidance no longer recommends COVID-19 vaccination beyond
the first booster in low risk population, citing high population-level hybrid immunity due to …
the first booster in low risk population, citing high population-level hybrid immunity due to …